ADAGIO Imatinib Nonadherence in CML Study: Clinical Implications
ADAGIO Imatinib Nonadherence in CML Study: Clinical Implications
Isabel Cunningham, MD, Associate Editor
20090322
2009 Apr 22
ADAGIO Imatinib Nonadherence in CML Study: Clinical Implications
2009 Apr 22, Isabel Cunningham, MD, Associate Editor
The downside of oral cancer drugs is documented in this carefully executed Belgian study of imatinib in CML.
Editors' Choice
Long-Term Posttransplant Bortezomib Boosts Outcome in Myeloma With del(17p13)
Meet Our Experts
Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.
